Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Global Asthma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
Global Asthma Epidemiology and Patient Flow Analysis - 2021, provides Asthma epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.
The research provides population data to characterize Asthma patients, history of the disease at the population level (Asthma prevalence, Asthma incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.
Research scope:
- Asthma patient flow: Asthma prevalence, diagnosed, and drug-treated patients
- Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
- Demographics: Asthma patients by age group, gender
- Forecast: Asthma epidemiology forecast to 2035
The data from this research will help executives:
- Establish basis for Asthma market sizing, assessing market potential, and developing drug forecast models
- Identify Asthma patients segments through age groups, gender, and disease sub-types
- Develop Asthma population-based health management frameworks
- Evaluate Asthma market opportunities, identify target patient population
- Align marketing decisions with the Asthma target population
- Communicate leadership and health authorities about your Asthma target patient population
Key Topics Covered:
1. Research Methodology
2. Asthma Patients Definition
3. US Asthma Epidemiology and Patient Flow
4. Germany Asthma Epidemiology and Patient Flow
5. France Asthma Epidemiology and Patient Flow
6. Italy Asthma Epidemiology and Patient Flow
7. Spain Asthma Epidemiology and Patient Flow
8. UK Asthma Epidemiology and Patient Flow
9. Europe Asthma Epidemiology and Patient Flow
10. Japan Asthma Epidemiology and Patient Flow
11. Global Asthma Epidemiology and Patient Flow
For more information about this report visit https://www.researchandmarkets.com/r/v9aiqh